Keywords: astrazeneca, gains, expanded, indication, oxis, turbuhaler, received

AstraZeneca gains expanded indication for Oxis Turbuhaler

Article | 05 January 2000

Print This

AstraZeneca has received European Union backing to market its OxisTurbuhaler (formoterol) for the "as needed" treatment of asthma symptoms in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in